MONOPAR THERAPEUTICS (MNPR): Price and Financial Metrics

MONOPAR THERAPEUTICS (MNPR): $19.00

0.01 (-0.05%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add MNPR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#198 of 332

in industry

MNPR Price/Volume Stats

Current price $19.00 52-week high $38.50
Prev. close $19.01 52-week low $1.37
Day low $18.60 Volume 121,400
Day high $21.18 Avg. volume 676,958
50-day MA $10.09 Dividend yield N/A
200-day MA $5.05 Market Cap 100.28M

MNPR Stock Price Chart Interactive Chart >


MONOPAR THERAPEUTICS (MNPR) Company Bio


Monopar Therapeutics, Inc. engages in developing orphan oncology drugs. The company was founded by Chandler D. Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.


MNPR Latest News Stream


Event/Time News Detail
Loading, please wait...

MNPR Latest Social Stream


Loading social stream, please wait...

View Full MNPR Social Stream

MNPR Price Returns

1-mo 261.90%
3-mo 639.30%
6-mo 504.23%
1-year 1,129.77%
3-year -17.75%
5-year N/A
YTD 1,016.99%
2023 -85.65%
2022 -26.17%
2021 -47.55%
2020 -63.13%
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!